Clinical Trials

The purpose of this study is to evaluate the functionality and acceptability of HeraBEAT™ Smartphone based Fetal Heart Rate monitoring device when self-administered and used by low-risk pregnant women to monitor fetal heart rate during pregnancy.

The purpose of this study is to determine the characteristics of immune tolerance phenotypes in primiparous and multiparous pregnancies of same versus differing paternity.

The purpose of this study is to explore the experiences of patients at the Community Health Services, Inc. Clinic in Rochester, MN who are pregnant or are caring for an infant by understanding what it is like to be pregnant and plans to care for yourself and the baby.

The primary objective of the study is to assess the clinical utility of combining noninvasive prenatal testing (NIPT)-based zygosity measurements with ultrasound chorionicity assessments for the management of twin pregnancies, as measured by the following endpoints:  the overall frequency of NIPT-determined zygosity and monozygosity among twin pregnancies, the frequency of NIPT-determined zygosity rate among monochorionic and dichorionic twin pregnancies, and the proportion of twin pregnancies with twin-twin transfusion syndrome (TTTS) that are diagnosed late as compared with historical rates.

The objective of this study is to demonstrate the safety and performance of the Marani Fetal Monitoring Telehealth System (M•care™ System) for use in antenatal monitoring of pregnant women ≥ 32 weeks’ gestation. The M•care System will be evaluated by comparing Fetal Heart Rate (FHR), Maternal Heart Rate (MHR) and Uterine Contractions (UC) to Doppler FHR, tocodynamometer (TOCO) UC, and Pulse Oximeter MHR measured with an FDA cleared standard of care cardiotocography (CTG) device.

This is a multi-center, single arm, prospective paired comparison trial to determine the equivalence of the Marani M•care System with an FDA cleared Doppler FHR, TOCO UC ...